총 50 건의 최근 내부자 거래 내역가 기록되었습니다 Brainstorm Cell Therapeutics Inc. (BCLI), 포함 44 건 매수 및 1 건 매도. 내부자 매수 총액은 $575.32K 내부자 매도 총액은 $22.07K.
최근 활동이 있는 주요 내부자에는 Hartounian Hartoun, Frenkel Jacob A, Arbel Irit. 내부자 거래 내역는 경영진이 주식의 가치와 미래 전망을 어떻게 보는지에 대한 통찰을 제공할 수 있습니다.
내부자 거래 내역 — BCLI
| 날짜 |
이름 |
직책 |
거래 유형 |
주식수 |
평균 가격 |
금액 |
보유 주식수 |
| 2025-01-01 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
RSU 부여 |
50,000 |
- |
- |
52,000 |
| 2025-01-01 |
Frenkel Jacob A |
Director |
RSU 부여 |
40,000 |
- |
- |
43,777 |
| 2025-01-01 |
Arbel Irit |
Director |
RSU 부여 |
30,666 |
- |
- |
41,054 |
| 2025-01-01 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
120,000 |
- |
- |
200,960 |
| 2025-01-01 |
Yablonka Uri |
EVP & Chief Business Officer |
RSU 부여 |
40,000 |
- |
- |
48,464 |
| 2025-01-01 |
Patlis Alla |
See Remarks |
RSU 부여 |
40,000 |
- |
- |
44,349 |
| 2025-01-01 |
Polverino Anthony J. |
Director |
RSU 부여 |
24,000 |
- |
- |
25,730 |
| 2025-01-01 |
Lindborg Stacy |
Director |
RSU 부여 |
20,000 |
- |
- |
48,229 |
| 2025-01-01 |
Bairu Menghisteab |
Director |
RSU 부여 |
24,000 |
- |
- |
24,000 |
| 2025-01-01 |
Naor Nir |
Director |
RSU 부여 |
30,666 |
- |
- |
31,465 |
| 2025-01-01 |
Dagher Ibrahim B. |
Chief Medical Officer |
RSU 부여 |
50,000 |
- |
- |
66,849 |
| 2024-10-01 |
Lebovits Chaim |
President & CEO |
정보 매수 |
1,836 |
$3.43 |
$6.29K |
80,960 |
| 2024-09-30 |
Lebovits Chaim |
President & CEO |
정보 매수 |
22,000 |
$0.23 |
$5.02K |
1,186,865 |
| 2024-07-19 |
Dagher Ibrahim B. |
Chief Medical Officer |
정보 매도 |
63,000 |
$0.35 |
$22.07K |
- |
| 2024-06-24 |
Hartounian Hartoun |
Officer |
알 수 없음 |
- |
- |
- |
- |
| 2024-06-24 |
Hartounian Hartoun |
EVP, Chief Operating Officer |
RSU 부여 |
30,000 |
- |
- |
30,000 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-28 |
Lebovits Chaim |
President & CEO |
정보 매수 |
15,000 |
$0.52 |
$7.77K |
1,164,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-22 |
Lebovits Chaim |
President & CEO |
정보 매수 |
25,000 |
$0.64 |
$16K |
1,149,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-21 |
Lebovits Chaim |
President & CEO |
정보 매수 |
25,000 |
$0.58 |
$14.48K |
1,124,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-13 |
Lebovits Chaim |
President & CEO |
정보 매수 |
10,000 |
$0.49 |
$4.9K |
1,099,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-11 |
Lebovits Chaim |
President & CEO |
정보 매수 |
10,000 |
$0.47 |
$4.67K |
1,089,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-10 |
Lebovits Chaim |
President & CEO |
정보 매수 |
20,000 |
$0.47 |
$9.3K |
1,079,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-07 |
Lebovits Chaim |
President & CEO |
정보 매수 |
66,300 |
$0.37 |
$24.82K |
1,059,865 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-05-06 |
Lebovits Chaim |
President & CEO |
정보 매수 |
135,000 |
$0.38 |
$50.67K |
993,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-19 |
Lebovits Chaim |
President & CEO |
정보 매수 |
15,000 |
$0.52 |
$7.8K |
858,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-18 |
Lebovits Chaim |
President & CEO |
정보 매수 |
115,072 |
$0.53 |
$60.47K |
843,565 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
알 수 없음 |
80,000 |
$1.73 |
$138.4K |
- |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-04-17 |
Dagher Ibrahim B. |
Chief Medical Officer |
알 수 없음 |
- |
- |
- |
30,000 |
| 2024-04-17 |
Lebovits Chaim |
President & CEO |
정보 매수 |
130,000 |
$0.55 |
$70.94K |
728,493 |
| 2024-03-11 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
305,198 |
- |
- |
598,493 |
| 2024-03-11 |
Yablonka Uri |
EVP & Chief Business Officer |
RSU 부여 |
109,426 |
- |
- |
126,969 |
| 2024-03-11 |
Patlis Alla |
See Remarks |
RSU 부여 |
65,246 |
- |
- |
65,246 |
| 2024-03-11 |
Lindborg Stacy |
Co-chief Executive Officer |
RSU 부여 |
241,935 |
- |
- |
423,435 |
| 2023-09-01 |
Lindborg Stacy |
Co-chief Executive Officer |
정보 매수 |
11,500 |
$1.77 |
$20.4K |
181,500 |
| 2023-08-02 |
Lebovits Chaim |
President & CEO |
RSU 부여 |
31,185 |
- |
- |
293,295 |
| 2023-08-02 |
Lindborg Stacy |
Co-chief Executive Officer |
RSU 부여 |
35,000 |
- |
- |
170,000 |
| 2023-06-19 |
Naor Nir |
Director |
알 수 없음 |
- |
- |
- |
- |
| 2023-06-19 |
Naor Nir |
Director |
RSU 부여 |
11,999 |
- |
- |
11,999 |
| 2023-05-01 |
Taylor Kirk |
Officer |
알 수 없음 |
- |
- |
- |
- |
■ 정보 기반 — 공개 시장 거래 (가장 중요)
■ 비정보 매수 — 보상, 옵션 행사, 전환
■ 비정보 매도 — 세금 원천징수, 부여 매도
■ 중립 — 증여, 신탁, 만료
